Why the study?
Very few studies have investigated the effects of initiating, increasing, decreasing, or stopping antihypertensive treatment in the very old (85 years), where increasing co-morbidities and side effects affect the risk/benefit ratio.
Should antihypertensive treatment be stopped, initiated, or modified in very old patients (≥85 years)?
Should antihypertensive treatment be stopped, initiated, or modified in very old patients (≥85 years)?
The risk/benefit ratio of antihypertensive treatment in the very old (≥85 years) is affected by increasing co-morbidities and side effects, though some benefit is still assumed.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bo Carlberg (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: